Literature DB >> 12856639

Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen.

Jianzhou Wang1, Michael Torbenson, Qi Wang, Jae Y Ro, Michael Becich.   

Abstract

Nitric oxide (NO) is an important signaling molecule for ischemia, inflammation, angiogenesis, immune response, and cell growth and differentiation. It has recently been shown that increased production of NO within various human cancers may contribute to tumor angiogenesis, tumor growth and metastasis, and tumor-related immune suppression. NO can be produced by several NO synthases (NOS), including inducible synthase (iNOS), which is expressed during cell activation and produces NO in larger quantity and for a longer period of time than non-inducible NOSs. In this study, we examined the expression levels of iNOS mRNA and protein in prostate adenocarcinoma using a paired nonneoplastic and neoplastic primary prostate cell culture system and related prostatectomy specimens. Six pairs of neoplastic and nonneoplastic primary prostate cell cultures were established from radical prostatectomy specimens based on homogeneity of the originating tumor and the nonneoplastic tissue. Radioactive reverse transcriptase polymerase chain reaction and subsequent quantitative analysis of iNOS mRNA were performed on the cultures using beta-actin as an internal control. Immunohistochemical studies with an anti-iNOS monoclonal antibody were performed on the corresponding formalin-fixed paraffin-embedded prostatectomy tissue sections. We observed marked patient-to-patient variation in "normal" levels of iNOS mRNA. However, all six neoplastic cultures showed moderately to markedly higher mRNA levels than did their paired nonneoplastic cultures. In addition, iNOS protein levels were significantly higher in paraffin-embedded prostate cancer tissue sections than in adjacent nonneoplastic tissue. Overexpression of iNOS mRNA and protein levels is present in moderately differentiated prostate adenocarcinoma and may contribute to prostate cancer angiogenesis, tumor growth, and tumor-related immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12856639     DOI: 10.1016/s1078-1439(02)00208-9

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  10 in total

Review 1.  T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics.

Authors:  Yael S Barach; Jun Sik Lee; Xingxing Zang
Journal:  Trends Mol Med       Date:  2011-01       Impact factor: 11.951

2.  Significance of inducible nitric oxide synthase expression in benign and malignant breast epithelium: an immunohistochemical study of 151 cases.

Authors:  Asiye Safak Bulut; Esra Erden; Serpil Dizbay Sak; Hatice Doruk; Nazmiye Kursun; Dilek Dincol
Journal:  Virchows Arch       Date:  2005-06-10       Impact factor: 4.064

3.  Is Nitric Oxide (NO) the Last Word in Radiosensitization? A Review.

Authors:  Bryan T Oronsky; Susan J Knox; Jan J Scicinski
Journal:  Transl Oncol       Date:  2012-04-01       Impact factor: 4.243

4.  Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer.

Authors:  Jennifer D Wu; Lily M Higgins; Alexander Steinle; David Cosman; Kathy Haugk; Stephen R Plymate
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

5.  DNA methylation of oxidative stress genes and cancer risk in the Normative Aging Study.

Authors:  Tao Gao; Brian Thomas Joyce; Lei Liu; Yinan Zheng; Qi Dai; Zhou Zhang; Wei Zhang; Martha J Shrubsole; Meng-Hua Tao; Joel Schwartz; Andrea Baccarelli; Lifang Hou
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

6.  Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers.

Authors:  Vincenzo Bronte; Tihana Kasic; Giorgia Gri; Keti Gallana; Giovanna Borsellino; Ilaria Marigo; Luca Battistini; Massimo Iafrate; Tommaso Prayer-Galetti; Francesco Pagano; Antonella Viola
Journal:  J Exp Med       Date:  2005-04-11       Impact factor: 14.307

Review 7.  NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.

Authors:  Jan Scicinski; Bryan Oronsky; Shoucheng Ning; Susan Knox; Donna Peehl; Michelle M Kim; Peter Langecker; Gary Fanger
Journal:  Redox Biol       Date:  2015-07-02       Impact factor: 11.799

8.  The expressions of AMACR and iNOS in prostate adenocarcinomas.

Authors:  Tumay Ozgur; Esin Atik; Sibel Hakverdi; Mehmet Yaldiz
Journal:  Pak J Med Sci       Date:  2013-04       Impact factor: 1.088

9.  S-nitrosylation of Ras in breast cancer.

Authors:  Harvey E Marshall; Matthew W Foster
Journal:  Breast Cancer Res       Date:  2012-11-12       Impact factor: 6.466

10.  Prognostic Value of Inducible Nitric Oxide Synthase (iNOS) in Human Cancer: A Systematic Review and Meta-Analysis.

Authors:  Wenbiao Liao; Tao Ye; Haoran Liu
Journal:  Biomed Res Int       Date:  2019-06-04       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.